Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000658331 | SCV000780103 | likely benign | not provided | 2022-07-21 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ambry Genetics | RCV002397338 | SCV002674445 | uncertain significance | Inborn genetic diseases | 2017-07-27 | criteria provided, single submitter | clinical testing | The p.S257N variant (also known as c.770G>A), located in coding exon 3 of the IQSEC2 gene, results from a G to A substitution at nucleotide position 770. The serine at codon 257 is replaced by asparagine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003767895 | SCV004679439 | likely benign | Intellectual disability, X-linked 1 | 2024-10-24 | criteria provided, single submitter | clinical testing |